EdgeMarketInstruments › OCSAW

OCSAW — Oculis Holding AG

US Healthcare Pharma & biotech equity
5.08 +1.21% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 3.63 · high 22.30

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-05-13.

Performance

1 day+1.21%
1 week+1.70%
1 month+27.12%
3 months-74.14%
6 months-71.32%
Year to date-40.60%
1 year-23.65%
3 years+239.00%
5 years+551.92%

Technicals

RSI 1476.4
vs 50-day avg+11.93%
vs 200-day avg-54.42%
Volatility 1y113.0%
Max drawdown 1y-83.72%
Avg volume 30d2.4K
Daily bars held1,325
History from2021-05-13

Largest institutional holders

managervalueshares
MMCAP International Inc. SPC949.3K73.0K
JANE STREET GROUP, LLC594.1K45.7K
MOORE CAPITAL MANAGEMENT, LP541.7K41.7K
D. E. Shaw & Co., Inc.451.3K34.7K
WOLVERINE ASSET MANAGEMENT LLC101.1K7.8K
UBS Group AG4.1K270
Vestcor Inc19411.7K
Mint Tower Capital Management B.V.765.8K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
6-K2026-08-102026-08-10on EDGAR ↗
S-82026-08-06on EDGAR ↗
6-K2026-08-062026-06-30on EDGAR ↗
6-K2026-06-252026-06-25on EDGAR ↗
6-K2026-06-012026-05-29on EDGAR ↗
6-K2026-05-142026-05-14on EDGAR ↗
6-K2026-05-112026-03-31on EDGAR ↗
SCHEDULE 13G/A2026-04-29on EDGAR ↗

Short selling

Avg short volume, 90d56.3% of tape
Days observed36

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Ask the AI about OCSAW

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open OCSAW in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →